Oracle made a $300 billion bet on OpenAI. It's paying the price.

Oracle shares have plunged nearly 40% from their September peak, erasing more than $360 billion of market value — including a nearly $67 billion one-day drop after Q2 results failed to allay investor fears that the company is overexposed to OpenAI. Oracle's previously disclosed remaining performance obligations jumped about 360% to $455 billion in September, with at least $300 billion tied to OpenAI's Stargate project, and analysts warn that OpenAI's mounting infrastructure commitments (estimated at about $1.4 trillion) and rising competition from Google's Gemini threaten its ability to pay, leaving Oracle on the hook to build capacity. The company’s Q2 numbers deepened concerns — $12 billion in capex, a $10 billion free-cash-flow loss versus a $6 billion forecast, and a raised full-year capex target of $50 billion from $35 billion — increasing leverage and cash-flow risk even after management’s reassurances.

Analysis

Oracle shares have fallen nearly 40% from their September peak, erasing more than $360 billion of market value and suffering a roughly $67 billion one-day drop after Q2 results failed to address investor concerns about concentration of revenue exposure to OpenAI. The company had previously reported remaining performance obligations (RPO) up about 360% to $455 billion in September, and at least $300 billion of that RPO has been publicly attributed to OpenAI’s Stargate project, concentrating future revenue risk in a single counterparty.

Oracle’s Q2 operational metrics amplified funding and liquidity concerns: capital expenditures of $12 billion exceeded expectations while free cash flow showed a $10 billion outflow versus a $6 billion anticipated loss, and management raised full-year capex guidance to $50 billion from $35 billion. Those moves increase near-term leverage and growth-capex funding needs just as analysts flag potential collection risk from OpenAI.

Analyst commentary frames the core risk as OpenAI’s ability to pay its infrastructure commitments—estimated in the article at roughly $1.4 trillion across partners—and growing competitive pressure from Google’s Gemini product set. The practical implications for investors are binary: Oracle may be forced to build and finance capacity for a counterparty that could struggle to monetize its services, making near-term credit, cash-flow, and RPO transparency the primary monitoring points for the stock’s recovery or further deterioration.

Key Decisions for Investors

• Reduce or cap incremental exposure to ORCL until Oracle provides an audited, line-item breakdown of RPO tied to OpenAI and clearer contract/payment terms
• Hedge existing ORCL positions or use downside protection given the raised $50 billion capex outlook and the $10 billion Q2 free-cash-flow shortfall
• Monitor near-term catalysts: OpenAI monetization signals (including any revisions tied to Sam Altman’s 'code red'), Oracle quarterly capex and FCF updates, and any third-party confirmations or renegotiations of Stargate commitments
• Consider selective exposure to diversified AI infrastructure providers only after validating their counterparty concentration and balance-sheet resilience, and watch Google (GOOG) competitive developments as a sector-level risk indicator